Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - celecoxib -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - celecoxib -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - celecoxib, quantity: 200 mg - capsule, hard - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; sodium lauryl sulfate; croscarmellose sodium; titanium dioxide; purified water; iron oxide yellow; gelatin; acetic acid; silicon dioxide; citric acid; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,- for the treatment of primary dysmenorrhoea in adults.,- for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - celecoxib, quantity: 100 mg - capsule, hard - excipient ingredients: croscarmellose sodium; lactose monohydrate; sodium lauryl sulfate; magnesium stearate; povidone; titanium dioxide; brilliant blue fcf; purified water; allura red ac; gelatin; acetic acid; silicon dioxide; citric acid; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - - for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.,- for the treatment of primary dysmenorrhoea in adults.,- for the short-term treatment of acute pain in adults following surgery or musculoskeletal and/or soft tissue injury.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cipla usa inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ]. for the management of the signs and symptoms of ra [see clinical studies (14.2) ]. for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ]. for the management of the signs and symptoms of as [see clinical studies (14.4) ]. for the management of acute pain in adults [see clinical studies (14.5) ]. for the management of primary dysmenorrhea [see clinical studies (14.5) ]. celecoxib capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [see warnings and precautions (5.7, 5

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

bryant ranch prepack - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules  are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celecoxib is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see   warnings and precautions ( 5.7 , 5.9 )] . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [see warnings and precautions ( 5.7 , 5

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

bryant ranch prepack - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1)] . for the management of the signs and symptoms of ra [see clinical studies (14.2)] . for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] . for the management of the signs and symptoms of as [see clinical studies (14.4)] . for the management of acute pain in adults [see clinical studies (14.5)] . for the management of primary dysmenorrhea [see clinical studies (14.5)] . celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of celecoxib capsules i

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - carefully consider the potential benefits and risks of celecoxib capsules and other treatment options before deciding to use celecoxib capsules. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5)] celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1)] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2)] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4)] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5)] celecoxib is indicated for the treatment of pd [see clinical studies (14.5)] celecoxib is contraindicated: - in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. in patients with known hypersensitivity to

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of cele

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

st. mary's medical park pharmacy - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - carefully consider the potential benefits and risks of celecoxib capsules and other treatment options before deciding to use celecoxib capsules. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions ( 5) ]. celecoxib capsules are indicated for relief of the signs and symptoms of oa [ see clinical studies ( 14.1) ]. celecoxib capsules are indicated for relief of the signs and symptoms of ra [ see clinical studies ( 14.2) ]. celecoxib capsules are indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies ( 14.3) ]. celecoxib capsules are indicated for the relief of signs and symptoms of as [ see clinical studies ( 14.4) ]. celecoxib capsules are indicated for the management of ap in adults [ see clinical studies ( 14.5) ]. celecoxib capsules are indicated for the treatment of pd [ see clinical studies ( 14.5) ]. celecoxib capsules are contraindicated: - in patients with known hype